Search research articles
Contact Us
Filters
Showing results (261-270 of 2,048) with videos related to
Page
of 205
Sort By:
The International Journal of Health Planning and Management
|
February 24, 2001
Demanding healthcare
A Mark, D Pencheon, R Elliott
Archives of Dermatology
|
September 18, 2001
In favor of antibiotic prophylaxis for laser resurfacing
K A Mark, D S Sarnoff
Circulation
|
July 7, 2005
N-terminal-pro-B-type natriuretic peptide: universal marker of cardiovascular risk?
A Mark Richards, Christopher M Frampton
Urology
|
June 4, 2021
The Economics of Viagra Revisited: The Price Is Right
Nnenaya Agochukwu-Mmonu, A Mark Fendrick
Alimentary Pharmacology & Therapeutics
|
May 25, 2022
Editorial: estimating the costs of care in irritable bowel syndrome-a necessary step to enhance value-based care for a high-prevalence, low-cost condition
Jeffrey A Berinstein, A Mark Fendrick
The American Journal of Managed Care
|
July 19, 2019
Precision medicines need precision patient assistance programs
A Mark Fendrick, Jason D Buxbaum
Trends in Cardiovascular Medicine
|
March 18, 2019
MY APPROACH to Commotio Cordis
N A Mark Estes, Jonathan Weinstock
JAMA Internal Medicine
|
January 19, 2017
Precision Benefit Design-Using "Smarter" Deductibles to Better Engage Consumers and Mitigate Cost-Related Nonadherence
A Mark Fendrick, Michael E Chernew
Journal of Oncology Practice
|
September 4, 2012
Transformation
John V Cox, A Mark Fendrick
Circulation
|
May 16, 2018
Natriuretic Peptide-Guided Heart Failure Therapy After the GUIDE-IT Study
James L Januzzi, A Mark Richards
Page
of 205
Search research articles
Search
Showing results (261-270 of 2,048) with videos related to
Sort By:
Page
of 205
The International Journal of Health Planning and Management
|
February 24, 2001
Demanding healthcare
A Mark, D Pencheon, R Elliott
Archives of Dermatology
|
September 18, 2001
In favor of antibiotic prophylaxis for laser resurfacing
K A Mark, D S Sarnoff
Circulation
|
July 7, 2005
N-terminal-pro-B-type natriuretic peptide: universal marker of cardiovascular risk?
A Mark Richards, Christopher M Frampton
Urology
|
June 4, 2021
The Economics of Viagra Revisited: The Price Is Right
Nnenaya Agochukwu-Mmonu, A Mark Fendrick
Alimentary Pharmacology & Therapeutics
|
May 25, 2022
Editorial: estimating the costs of care in irritable bowel syndrome-a necessary step to enhance value-based care for a high-prevalence, low-cost condition
Jeffrey A Berinstein, A Mark Fendrick
The American Journal of Managed Care
|
July 19, 2019
Precision medicines need precision patient assistance programs
A Mark Fendrick, Jason D Buxbaum
Trends in Cardiovascular Medicine
|
March 18, 2019
MY APPROACH to Commotio Cordis
N A Mark Estes, Jonathan Weinstock
JAMA Internal Medicine
|
January 19, 2017
Precision Benefit Design-Using "Smarter" Deductibles to Better Engage Consumers and Mitigate Cost-Related Nonadherence
A Mark Fendrick, Michael E Chernew
Journal of Oncology Practice
|
September 4, 2012
Transformation
John V Cox, A Mark Fendrick
Circulation
|
May 16, 2018
Natriuretic Peptide-Guided Heart Failure Therapy After the GUIDE-IT Study
James L Januzzi, A Mark Richards
Page
of 205